Peer-reviewedPublisher termsThe Cochrane Database of Systematic Reviews
Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease
- 1Library and Knowledge Service East Lancashire Hospitals NHS Trust Blackburn UK
- 2Chest Clinic East Lancashire Hospitals NHS Trust Blackburn UK
Related
- Disparities in α1-Antitrypsin Deficiency Testing and Treatment in US Adults
- Validation of the Bronchiectasis Severity Index in alpha-1 antitrypsin deficiency
- Ectopic rabphilin-3A expression in lung adenocarcinoma associated with paraneoplastic arginine vasopressin deficiency during anti-PD-L1 therapy: a case report.
- Disparities in α ₁ -Antitrypsin Deficiency Testing and Treatment in US Adults
- Prevalence and associated factors of vitamin B12 deficiency among Vietnamese patients with type 2 diabetes receiving metformin therapy: a cross-sectional study
BibTeX
@article{glaister2026alpha,
title = {{Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease}},
author = {Patrick Glaister and Nichola Hindle Robinson and Amy Woods and Chloe Bentham and Juiliana Hamzah and Iain Crossingham},
journal = {The Cochrane Database of Systematic Reviews},
year = {2026},
month = aug,
doi = {10.1002/14651858.cd015930.pub2},
url = {https://doi.org/10.1002/14651858.cd015930.pub2},
}
RIS
TY - JOUR
TI - Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease
AU - Patrick Glaister
AU - Nichola Hindle Robinson
AU - Amy Woods
AU - Chloe Bentham
AU - Juiliana Hamzah
AU - Iain Crossingham
PY - 2026
DA - 2026/08/21
JO - The Cochrane Database of Systematic Reviews
DO - 10.1002/14651858.cd015930.pub2
UR - https://doi.org/10.1002/14651858.cd015930.pub2
SN - 1469-493X
ER -